상세 보기
Subgroup analysis of patients (pts) with HER2-low metastatic breast cancer (mBC) with brain metastases (BMs) at baseline from DESTINY-Breast04, a randomized phase III study of trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC)
- Tsurutani, J.;
- Jacot, W.;
- Yamashita, T.;
- Riaz, F.;
- Yerushalmi, R.;
- ... Chae, Y.;
- 외 14명
Citations
WEB OF SCIENCE
17- 제목
- Subgroup analysis of patients (pts) with HER2-low metastatic breast cancer (mBC) with brain metastases (BMs) at baseline from DESTINY-Breast04, a randomized phase III study of trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC)
- 저자
- Tsurutani, J.; Jacot, W.; Yamashita, T.; Riaz, F.; Yerushalmi, R.; Im, S-A.; Niikura, N.; Halser-Strub, U.; Cortes, J.; Wennstig, A-K.; Chae, Y.; Wang, X.; Li, W.; Simon, H.; Masci, G.; Tamburini, E.; Aguilar, C. Orbegoso; Tecson, K.; Yung, L.; Modi, S.
- 발행일
- 2023-10
- 유형
- Meeting Abstract
- 권
- 34
- 페이지
- S342 ~ S343
- 언어
- ENG
- 출판사
- ELSEVIER
- 발행국가
- 네덜란드
- ISSN
- E 1569-8041
P 0923-7534